Michael S. Leibowitz
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cytokine Signaling Pathways and Interactions
Papers in
- Oncology 9
- Peptidase Inhibition and Analysis 3
- Cancer Immunotherapy and Biomarkers 2
- Cytokine Signaling Pathways and Interactions 2
- Cancer-related Molecular Pathways 2
- CAR-T cell therapy research 2
-
- Immunotherapy and Immune Responses 5
- Immune Cell Function and Interaction 3
- Co-authors
- Robert L. Ferris (6 shared papers)Pedro A. Andrade Filho (2 shared papers)Soldano Ferrone (2 shared papers)Steven Μ. Albelda (3 shared papers)Robert H. Vonderheide (2 shared papers)Daniel H. Sterman (1 shared paper)Peter DeLong (1 shared paper)Carl H. June (1 shared paper)
- Journals
- Clinical Cancer Research (2 papers)Cancer Research (2 papers)Current Oncology Reports (1 paper)Cancer Biology & Therapy (1 paper)Molecular Diagnosis & Therapy (1 paper)
- Partner nations
- United StatesSlovakiaRussia
In The Last Decade
Michael S. Leibowitz
14 papers receiving 495 citations
Peers
Comparison fields: 5 of 58
- Immunology 262
- Oncology 315
- Otorhinolaryngology 27
- Biotechnology 32
- Pulmonary and Respiratory Medicine 106
Countries citing papers authored by Michael S. Leibowitz
This map shows the geographic impact of Michael S. Leibowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Leibowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Leibowitz more than expected).
Fields of papers citing papers by Michael S. Leibowitz
This network shows the impact of papers produced by Michael S. Leibowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Leibowitz. The network helps show where Michael S. Leibowitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael S. Leibowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 99 | |
| 2 | 2011 | 84 | |
| 3 | 2007 | 75 | |
| 4 | 2013 | 63 | |
| 5 | 2008 | 39 | |
| 6 | 2020 | 38 | |
| 7 | 2019 | 25 | |
| 8 | 2007 | 24 | |
| 9 | 2008 | 24 | |
| 10 | 2008 | 15 | |
| 11 | 2009 | 8 | |
| 12 | 2019 | 6 | |
| 13 | 2018 | 4 | |
| 14 | 2024 | 1 |
About Michael S. Leibowitz
Michael S. Leibowitz is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Biotechnology, having authored 14 papers that have together received 505 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), Peptidase Inhibition and Analysis (3 papers), Immune Cell Function and Interaction (3 papers), Cancer Research and Treatments (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Cancer-related Molecular Pathways (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Immunology (262 citations), Oncology (315 citations), Otorhinolaryngology (27 citations), Biotechnology (32 citations) and Pulmonary and Respiratory Medicine (106 citations). Michael S. Leibowitz has collaborated with scholars based in United States, Slovakia and Russia. Frequent co-authors include Robert L. Ferris, Pedro A. Andrade Filho, Soldano Ferrone, Steven Μ. Albelda, Robert H. Vonderheide, Daniel H. Sterman, Peter DeLong, Carl H. June, Richard G. Carroll and Sajjad Ahmad. Their work appears in journals such as Clinical Cancer Research, Cancer Research, Current Oncology Reports, Cancer Biology & Therapy and Molecular Diagnosis & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.